Fundraising Fox

Biotech Investors & VC Firms

2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.

OMX Ventures
LincolnshireSeed–Series A
9 people
AQC Capital
MontrealPre-Seed–Series A
20 people
BioHealth Innovation, Inc.
Rockville
20 people
Emerald Development Managers
New YorkSeed–Late Stage
11 people
FSG
LundPre-Seed–Growth$1.1M – $6.5M
8 people
Fund+
LeuvenSeries A–Series B$5.5M – $16.5M
11 people
Hatcher+
Seed
20 people
Innovation Fund sa/nv
SchaerbeekSeed–Series B$270K – $2.7M
17 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
11 people
SCP Vitalife Partners
Tel AvivSeed–Late Stage$3M – $7M
11 people
TechVision Fund
AachenPre-Seed–Series A$550K – $2.2M
17 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
13 people
Bynd Venture Capital
LisbonPre-Seed–Series A
7 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
PS27 Ventures
JacksonvilleSeed–Series A$250K – $1M
10 people
Brunnur Ventures GP
ReykjavikPre-Seed–Series A$1M – $3M
9 people
Delta Partners
DublinPre-Seed–Series B$108K – $3.2M
6 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
9 people
Hongtai Capital Holdings
BeijingSeed–Late Stage
Iaso Ventures
CambridgeSeed–Series A
12 people
Newton Biocapital
BrusselsSeed–Series A
15 people
Northern Gritstone
Pre-Seed–Growth
6 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
6 people
Übermorgen Ventures
ZurichPre-Seed–Series A$330K – $1.1M
6 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.